<DOC>
	<DOC>NCT00850200</DOC>
	<brief_summary>The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal organs to low dose radiation.</brief_summary>
	<brief_title>Proton Therapy for Hodgkin Lymphoma</brief_title>
	<detailed_description>3 treatment plans will be created to deliver between a total of 21-39.6 Gray (Gy)/Centigray Equivalents (CGE) to the planning target volume (PTV). 1. Proton Plan 2. Conventional Plan 3. Intensity Modulated Radiotherapy (IMRT) Plan The patient will then receive the radiation modality with the lowest percentage of the body receiving 4 Gy (V4Gy/CGE)</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Confirmed "classic" Hodgkin lymphoma. Completed chemotherapy. Prior radiotherapy. Prior or concurrent cancer other than nonmelanomatous skin cancer.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hodgkin Lymphoma, Proton Radiation</keyword>
</DOC>